Forum uncovers unusual relationships
The recent GlaxoSmithKline (GSK) settlement with the IRS and taxpayer's continuing problems with intangibles were two of the issues that grabbed attention at International Tax Review's sixth annual Global Transfer Pricing Forum in London
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: